{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T10:47:57Z","timestamp":1764240477715,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:00:00Z","timestamp":1631923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:00:00Z","timestamp":1631923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872679"],"award-info":[{"award-number":["81872679"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007279","name":"Shanghai Municipal Health Bureau","doi-asserted-by":"publisher","award":["201840117"],"award-info":[{"award-number":["201840117"]}],"id":[{"id":"10.13039\/501100007279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Shanghai, as a pilot city of China to achieve the goal of eliminating hepatitis C, its strategy of allocating medical resources is a pressing problem to be solved. This study aims to infer the time-spatial clustering patterns of HCV-infected cases, and grasp the dynamic genotype distribution of HCV, thereby inform elimination strategies of HCV with efficacy and efficiency.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Reported HCV cases including their demographic information in Shanghai city from 2005 to 2018 were released from the National Infectious Disease Reporting Information System, population data at community scale, geographical layers of hospitals, communities and districts were gathered from former research. Blood samples of HCV-infected individuals were collected during 2014\u20132018 from 24 sentinel hospitals, HCV-antibody test, qualitative nucleic acid test and NS5B\/5\u2019UTR gene amplification were performed accordingly to determine the genotypes of the specimen. Furthermore, global and local spatial self-correlation analysis of both acute and chronic HCV infections were conducted at community scale year by year, then time-spatial clusters of acute and chronic HCV infections and HCV genotype distribution of specimen collected from sentinel hospitals by districts were mapped by using Arcmap10.1.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 2631 acute HCV cases and 15,063 chronic HCV cases were reported in Shanghai from 2005 to 2018, with a peak in 2010 and 2017, respectively. The mean age of chronic HCV patients was 49.70\u2009\u00b1\u200914.55\u00a0years, 3.34\u2009\u00b1\u20090.32\u00a0years older than the acute (<jats:italic>t<\/jats:italic>\u2009=\u200910.55, <jats:italic>P<\/jats:italic>-value\u2009&lt;\u20090.01). The spatial distribution of acute HCV infection formed one primary cluster (Relative Risk\u2009=\u20092.71), and the chronic formed one primary cluster and three secondary clusters with Relative Risk ranged from 1.94 to 14.42, meanwhile, an overlap of 34 communities between acute and chronic HCV clusters were found with time period spans varied from 6 to 12\u00a0years. Genotype 1 (N\u2009=\u2009257, 49.71%) was the most prevalent HCV genotype in Shanghai, genotype 3 infections have increased in recent years. Baoshan district presented cluster of acute HCV and the highest proportion of genotype 2, Pudong new area was the cluster of chronic HCV and occupied the highest proportion of genotype 3.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Despite the low prevalence of HCV infection, it is still needed to push forward the elimination process in Shanghai, as there is a certain amount of HCV infected people waiting to be treated. The time-spatial clustering patterns and the dynamic of HCV genotype distribution together indicated a changing constitution of different transmission routes of HCV infection, thus, a focused strategy may be needed for high-risk population related to genotype 3 infection like drug users, in addition to an enforcement of the existing measures of preventing the iatrogenic and hematogenic transmission of HCV.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-021-06577-8","type":"journal-article","created":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T20:02:49Z","timestamp":1631995369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The distribution of hepatitis C virus infection in Shanghai, China: a time-spatial study"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4278-044X","authenticated-orcid":false,"given":"Ling-Xiao","family":"Qu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Han","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9657-8832","authenticated-orcid":false,"given":"Hong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,18]]},"reference":[{"issue":"4","key":"6577_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jhep.2006.05.013","volume":"45","author":"JF Perz","year":"2006","unstructured":"Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45(4):529\u201338. https:\/\/doi.org\/10.1016\/j.jhep.2006.05.013.","journal-title":"J Hepatol"},{"issue":"6","key":"6577_CR2","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142(6):1264-73.e1. https:\/\/doi.org\/10.1053\/j.gastro.2011.12.061.","journal-title":"Gastroenterology"},{"key":"6577_CR3","unstructured":"World Health Organization. Global hepatitis report, 2017. 2017 (cited 2020 Nov 5). http:\/\/www.who.int\/hepatitis\/publications\/global-hepatitis-report2017\/en\/."},{"key":"6577_CR4","unstructured":"World Health Organization. Global health sector strategy on viral hepatitis 2016\u20132021. 2016 (cited 2020 Nov 5). http:\/\/www.who.int\/hepatitis\/strategy2016-2021\/ghss-hep\/en\/."},{"key":"6577_CR5","unstructured":"World Health Organization. Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. 2018 (cited 2020 Nov 5). https:\/\/apps.who.int\/iris\/handle\/10665\/273174."},{"key":"6577_CR6","doi-asserted-by":"publisher","first-page":"704912","DOI":"10.1155\/2013\/704912","volume":"2013","author":"HB Chae","year":"2013","unstructured":"Chae HB, Park SM, Youn SJ. Direct-acting antivirals for the treatment of chronic hepatitis C: open issues and future perspectives. Sci World J. 2013;2013:704912. https:\/\/doi.org\/10.1155\/2013\/704912.","journal-title":"Sci World J"},{"issue":"22","key":"6577_CR7","doi-asserted-by":"publisher","first-page":"12041","DOI":"10.1128\/JVI.01773-13","volume":"87","author":"L Lu","year":"2013","unstructured":"Lu L, Tong W, Gu L, Li C, Lu T, Tee KK, et al. The current hepatitis C virus prevalence in China may have resulted mainly from an officially encouraged plasma campaign in the 1990s: a coalescence inference with genetic sequences. J Virol. 2013;87(22):12041\u201350. https:\/\/doi.org\/10.1128\/JVI.01773-13.","journal-title":"J Virol"},{"issue":"Suppl 1","key":"6577_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/jgh.12220","volume":"28","author":"Y Cui","year":"2013","unstructured":"Cui Y, Jia J. Update on epidemiology of hepatitis B and C in China. J Gastroenterol Hepatol. 2013;28(Suppl 1):7\u201310. https:\/\/doi.org\/10.1111\/jgh.12220.","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"6577_CR9","first-page":"888","volume":"32","author":"YS Chen","year":"2011","unstructured":"Chen YS, Li L, Cui FQ, Xing WG, Wang L, Jia ZY, et al. A sero-epidemiological study on hepatitis C in China. Chin J Epidemiol. 2011;32(9):888\u201391.","journal-title":"Chin J Epidemiol"},{"issue":"1","key":"6577_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12985-017-0710-z","volume":"14","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Chen LM, He M. Hepatitis C Virus in mainland China with an emphasis on genotype and subtype distribution. Virol J. 2017;14(1):41. https:\/\/doi.org\/10.1186\/s12985-017-0710-z.","journal-title":"Virol J"},{"key":"6577_CR11","unstructured":"National Medical Insurance Bureau, Ministry of Human Resources and Social Security. National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List. 2019 (cited 2020 Jul 14). http:\/\/www.nhsa.gov.cn\/art\/2019\/8\/20\/art_37_1666.html."},{"key":"6577_CR12","doi-asserted-by":"publisher","unstructured":"National Health and Family Planning Commission, National Development and Reform Commission, Ministry of Education, Ministry of Science and Technology, Ministry of Industry and Information Technology, Ministry of Public Security, et al. Action plan for the prevention and treatment of viral hepatitis in China (2017\u20132020). Chin J Viral Dis. 2018; 8(01):1\u20135. https:\/\/doi.org\/10.16505\/j.2095-0136.2018.0001(Chinese.)","DOI":"10.16505\/j.2095-0136.2018.0001"},{"key":"6577_CR13","doi-asserted-by":"publisher","unstructured":"Chinese Society of Hepatology; Chinese Society of Infectious Diseases, Chinese Medical Association. Guidelines for the prevention and treatment of hepatitis C (2019 version). Zhonghua Gan Zang Bing Za Zhi. 2019;27(12):962\u2013979. https:\/\/doi.org\/10.3760\/cma.j.issn.1007-3418.2019.12.008(Chinese).","DOI":"10.3760\/cma.j.issn.1007-3418.2019.12.008"},{"issue":"1","key":"6577_CR14","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/hep.26744","volume":"59","author":"DB Smith","year":"2014","unstructured":"Smith DB, Bukh J, Kuiken C, Muerhoff AS, Rice CM, Stapleton JT, Simmonds P. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology. 2014;59(1):318\u201327. https:\/\/doi.org\/10.1002\/hep.26744.","journal-title":"Hepatology"},{"issue":"4","key":"6577_CR15","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/jmv.20307","volume":"75","author":"L Lu","year":"2005","unstructured":"Lu L, Nakano T, He Y, Fu Y, Hagedorn CH, Robertson BH. Hepatitis C virus genotype distribution in China: predominance of closely related subtype 1b isolates and existence of new genotype 6 variants. J Med Virol. 2005;75(4):538\u201349. https:\/\/doi.org\/10.1002\/jmv.20307.","journal-title":"J Med Virol"},{"issue":"1","key":"6577_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1365-2893.2010.01280.x","volume":"18","author":"Y Fu","year":"2011","unstructured":"Fu Y, Wang Y, Xia W, Pybus OG, Qin W, Lu L, Nelson K. New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors. J Viral Hepat. 2011;18(1):42\u201352. https:\/\/doi.org\/10.1111\/j.1365-2893.2010.01280.x.","journal-title":"J Viral Hepat"},{"key":"6577_CR17","doi-asserted-by":"publisher","first-page":"5232","DOI":"10.12659\/MSM.907424","volume":"24","author":"JH Lei","year":"2018","unstructured":"Lei JH, Liang J, Gong X, Xiao XQ, Chen Z, Peng F. Analysis of transmission routes of hepatitis C virus based on virus genotyping in 341 cases with different suspected initial infection time points in Hunan Province, China. Med Sci Monit. 2018;24:5232\u201341. https:\/\/doi.org\/10.12659\/MSM.907424.","journal-title":"Med Sci Monit"},{"key":"6577_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-020-00588-3","author":"C Stasi","year":"2020","unstructured":"Stasi C, Silvestri C, Voller F. Update on hepatitis C epidemiology: unaware and untreated infected population could be the key to elimination. SN Compr Clin Med. 2020. https:\/\/doi.org\/10.1007\/s42399-020-00588-3 (Epub ahead of print).","journal-title":"SN Compr Clin Med."},{"issue":"4","key":"6577_CR19","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/cid\/ciy541","volume":"68","author":"X Wang","year":"2019","unstructured":"Wang X, Wu P, Pei Y, Tsang TK, Gu D, Wang W, et al. Assessment of human-to-human transmissibility of avian influenza A(H7N9) virus across 5 waves by analyzing clusters of case patients in mainland China, 2013\u20132017. Clin Infect Dis. 2019;68(4):623\u201331. https:\/\/doi.org\/10.1093\/cid\/ciy541.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"6577_CR20","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3760\/cma.j.issn.0254-6450.2018.07.020","volume":"39","author":"XX Chen","year":"2018","unstructured":"Chen XX, Shi Y, Lu YH, Chen YH, Chen KY, Ren H. Spatial-temporal distribution characteristics of hepatitis E in Shanghai, 2006\u20132016. Chin J Epidemiol. 2018;39(7):971\u20136. https:\/\/doi.org\/10.3760\/cma.j.issn.0254-6450.2018.07.020 (Chinese).","journal-title":"Chin J Epidemiol."},{"issue":"7","key":"6577_CR21","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S1473-3099(18)30218-4","volume":"18","author":"C Yang","year":"2018","unstructured":"Yang C, Lu L, Warren JL, Wu J, Jiang Q, Zuo T, Gan M, et al. Internal migration and transmission dynamics of tuberculosis in Shanghai, China: an epidemiological, spatial, genomic analysis. Lancet Infect Dis. 2018;18(7):788\u201395. https:\/\/doi.org\/10.1016\/S1473-3099(18)30218-4.","journal-title":"Lancet Infect Dis"},{"key":"6577_CR22","unstructured":"Ministry of Health of the People\u2019s Republic of China. WS 213\u20132008 Diagnosis of hepatitis C (Chinese)."},{"key":"6577_CR23","unstructured":"National Health and Planning Commission of the People's Republic of China. WS 213\u20132018 Diagnosis of hepatitis C. J Clin Hepatol, 2018; (8):1619\u20131621. (Chinese)."},{"key":"6577_CR24","unstructured":"National Health and Planning Commission of the People's Republic of China. Screening and management of viral hepatitis C: WS\/T 453\u20132014; 2014 (Chinese)."},{"issue":"34","key":"6577_CR25","doi-asserted-by":"publisher","first-page":"7824","DOI":"10.3748\/wjg.v22.i34.7824","volume":"22","author":"A Petruzziello","year":"2016","unstructured":"Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol. 2016;22(34):7824\u201340. https:\/\/doi.org\/10.3748\/wjg.v22.i34.7824.","journal-title":"World J Gastroenterol"},{"issue":"12","key":"6577_CR26","doi-asserted-by":"publisher","first-page":"3231","DOI":"10.1007\/s00705-014-2185-1","volume":"159","author":"X Rong","year":"2014","unstructured":"Rong X, Xu R, Xiong H, Wang M, Huang K, Chen Q, et al. Increased prevalence of hepatitis C virus subtype 6a in China: a comparison between 2004\u20132007 and 2008\u20132011. Arch Virol. 2014;159(12):3231\u20137. https:\/\/doi.org\/10.1007\/s00705-014-2185-1.","journal-title":"Arch Virol"},{"issue":"12","key":"6577_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12985-015-0341-1","volume":"25","author":"W Ju","year":"2015","unstructured":"Ju W, Yang S, Feng S, Wang Q, Liu S, Xing H, et al. Hepatitis C virus genotype and subtype distribution in Chinese chronic hepatitis C patients: nationwide spread of HCV genotypes 3 and 6. Virol J. 2015;25(12):109. https:\/\/doi.org\/10.1186\/s12985-015-0341-1.","journal-title":"Virol J"},{"issue":"11","key":"6577_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/emi.2017.77","volume":"6","author":"Y Chen","year":"2017","unstructured":"Chen Y, Yu C, Yin X, Guo X, Wu S, Hou J. Hepatitis C virus genotypes and subtypes circulating in Mainland China. Emerg Microbes Infect. 2017;6(11): e95. https:\/\/doi.org\/10.1038\/emi.2017.77.","journal-title":"Emerg Microbes Infect"},{"key":"6577_CR29","doi-asserted-by":"publisher","first-page":"104488","DOI":"10.1016\/j.meegid.2020.104488","volume":"85","author":"VOL Castro","year":"2020","unstructured":"Castro VOL, Kamili S, Forbi JC, Stabile AC, da Silva EF, de Oliveira VLSM, et al. High prevalence of Hepatitis C Virus infection among people who use crack cocaine in an important international drug trafficking route in Central-West Region Brazil. Infect Genet Evol. 2020;85:104488. https:\/\/doi.org\/10.1016\/j.meegid.2020.104488.","journal-title":"Infect Genet Evol."},{"issue":"12","key":"6577_CR30","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","volume":"5","author":"L Degenhardt","year":"2017","unstructured":"Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192\u2013207. https:\/\/doi.org\/10.1016\/S2214-109X(17)30375-3.","journal-title":"Lancet Glob Health"},{"issue":"11","key":"6577_CR31","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1002\/jmv.24894","volume":"89","author":"J Lu","year":"2017","unstructured":"Lu J, Xiang X, Cao Z, Wang W, Zhao G, Tang W, et al. Younger trend of cirrhosis incidence in genotype 3 HCV infected patients in Eastern China. J Med Virol. 2017;89(11):1973\u201380. https:\/\/doi.org\/10.1002\/jmv.24894.","journal-title":"J Med Virol"},{"issue":"5","key":"6577_CR32","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1053\/jhep.2002.36366","volume":"36","author":"L Ming","year":"2002","unstructured":"Ming L, Thorgeirsson SS, Gail MH, Lu P, Harris CC, Wang N, et al. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China. Hepatology. 2002;36(5):1214\u201320. https:\/\/doi.org\/10.1053\/jhep.2002.36366.","journal-title":"Hepatology"},{"issue":"2","key":"6577_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016817","volume":"6","author":"C Zhang","year":"2011","unstructured":"Zhang C, Wu N, Liu J, Ge Q, Huang Y, Ren Q, Feng Q, He G. HCV subtype characterization among injection drug users: implication for a crucial role of Zhenjiang in HCV transmission in China. PLoS ONE. 2011;6(2): e16817. https:\/\/doi.org\/10.1371\/journal.pone.0016817.","journal-title":"PLoS ONE"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06577-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06577-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06577-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T20:03:30Z","timestamp":1631995410000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06577-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,18]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6577"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06577-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2021,9,18]]},"assertion":[{"value":"6 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol and utilization of hepatitis C morbidity data were reviewed by the Human Research Ethics Committee of Shanghai Municipal Center for Disease Control and Prevention. There was no ethical issue identified in the protocol. Therefore, our study was exempt from ethical review by our Investigation Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"974"}}